Literature DB >> 27648526

The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure.

S Yeo1, M-A Enoch1, E Gorodetsky1, L Akhtar1, K Schuebel1, A Roy2, D Goldman1.   

Abstract

The FK506 binding protein 51 (FKBP5), an intrinsic regulator of the glucocorticoid receptor, has been associated with pathological behaviors particularly in the context of childhood trauma (CT), via a putatively regulatory polymorphism, rs1360780. However, trans- and cis-acting effects of this locus and its interaction with CT are incompletely understood. To study its effects on the expression of glucocorticoid-regulated genes including FKBP5, we used lymphoblastoid cell lines (LCLs) derived from 16 CT-exposed patients with greater than two substance dependence/suicidal behavior diagnoses (casesCT+) and 13 non-CT-exposed controls (controlsCT-). This study in LCLs measures long-term trait-like differences attributable to genotype or lasting epigenetic modification. Through analysis of differential allelic expression (DAE) using an FKBP5 3'-UTR reporter single nucleotide polymorphism (SNP), rs3800373, that is in strong linkage disequilibrium with rs1360780, we confirmed that the rs1360780 risk allele (A) (or conceivably that of a linked SNP) leads to higher FKBP5 expression in controlsCT-. Intriguingly, casesCT+ did not show DAE, perhaps because of a genotype-predicted difference in FKBP5 DNA methylation restricted to casesCT+. Furthermore, through correlation analyses on FKBP5 expression at baseline and after induction by dexamethasone, we observed that casesCT+ had lower induction of FKBP5 expression, indicating that overall they may have strong ultra-short negative-feedback. Only casesCT+ showed an effect of rs1360780 genotype on expression of FKBP5 and other glucocorticoid-regulated genes. Together, these results confirm that the rs1360780 locus alters FKBP5 expression and further that in trans-fashion this locus affects the expression of other glucocorticoid-regulated genes after a glucocorticoid challenge. The CT exposure appears to be essential for trans-effects of rs1360780 on glucocorticoid-regulated genes.
© 2016 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  DNA methylation; FKBP5; cis-Acting regulation; differential allelic expression; glucocorticoid; glucocorticoid receptor; rs1360780; trans-acting effect; trauma; ultra-short negative-feedback

Mesh:

Substances:

Year:  2016        PMID: 27648526      PMCID: PMC6233292          DOI: 10.1111/gbb.12342

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  30 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.

Authors:  Gabriela M Wochnik; Joëlle Rüegg; G Alexander Abel; Ulrike Schmidt; Florian Holsboer; Theo Rein
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

3.  FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout mice.

Authors:  Ming-Chyi Huang; Melanie L Schwandt; Julia A Chester; Aaron M Kirchhoff; Chung-Feng Kao; Tiebing Liang; Jenica D Tapocik; Vijay A Ramchandani; David T George; Colin A Hodgkinson; David Goldman; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2014-03-07       Impact factor: 7.853

4.  Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study.

Authors:  Petra Zimmermann; Tanja Brückl; Agnes Nocon; Hildegard Pfister; Elisabeth B Binder; Manfred Uhr; Roselind Lieb; Terrie E Moffitt; Avshalom Caspi; Florian Holsboer; Marcus Ising
Journal:  Am J Psychiatry       Date:  2011-08-24       Impact factor: 18.112

5.  Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients.

Authors:  Andreas Menke; Janine Arloth; Benno Pütz; Peter Weber; Torsten Klengel; Divya Mehta; Mariya Gonik; Monika Rex-Haffner; Jennifer Rubel; Manfred Uhr; Susanne Lucae; Jan M Deussing; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2012-01-11       Impact factor: 7.853

6.  Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.

Authors:  W B Denny; D L Valentine; P D Reynolds; D F Smith; J G Scammell
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines.

Authors:  Eoin P Brennan; Mathias Ehrich; Derek P Brazil; John K Crean; Madeline Murphy; Denise M Sadlier; Finian Martin; Catherine Godson; Amy Jayne McKnight; Dirk van den Boom; Alexander P Maxwell; David A Savage
Journal:  Epigenetics       Date:  2009-04-18       Impact factor: 4.528

8.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.

Authors:  Elisabeth B Binder; Rebekah G Bradley; Wei Liu; Michael P Epstein; Todd C Deveau; Kristina B Mercer; Yilang Tang; Charles F Gillespie; Christine M Heim; Charles B Nemeroff; Ann C Schwartz; Joseph F Cubells; Kerry J Ressler
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

9.  Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.

Authors:  Harry Vermeer; Brenda I Hendriks-Stegeman; Bart van der Burg; Sylvia C van Buul-Offers; Maarten Jansen
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.

Authors:  Torsten Klengel; Divya Mehta; Christoph Anacker; Monika Rex-Haffner; Jens C Pruessner; Carmine M Pariante; Thaddeus W W Pace; Kristina B Mercer; Helen S Mayberg; Bekh Bradley; Charles B Nemeroff; Florian Holsboer; Christine M Heim; Kerry J Ressler; Theo Rein; Elisabeth B Binder
Journal:  Nat Neurosci       Date:  2012-12-02       Impact factor: 24.884

View more
  11 in total

1.  Examining FKBP5 mRNA expression in human iPSC-derived neural cells.

Authors:  Richard Lieberman; Henry R Kranzler; Eric S Levine; Jonathan Covault
Journal:  Psychiatry Res       Date:  2016-11-24       Impact factor: 3.222

2.  The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.

Authors:  Chuantao Zhang; Xiang Cui; Lian Feng; Zhiyi Han; Deti Peng; Wenjun Fu; Yufeng Xing
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 3.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

4.  Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus.

Authors:  Tobias Wiechmann; Simone Röh; Susann Sauer; Darina Czamara; Janine Arloth; Maik Ködel; Madita Beintner; Lisanne Knop; Andreas Menke; Elisabeth B Binder; Nadine Provençal
Journal:  Clin Epigenetics       Date:  2019-05-23       Impact factor: 6.551

5.  Fetal glucocorticoid receptor (Nr3c1) deficiency alters the landscape of DNA methylation of murine placenta in a sex-dependent manner and is associated to anxiety-like behavior in adulthood.

Authors:  Michaela Schmidt; Elad Lax; Rudy Zhou; David Cheishvili; Arne Mathias Ruder; Alessia Ludiro; Florian Lapert; Anna Macedo da Cruz; Paolo Sandrini; Teresa Calzoni; Farida Vaisheva; Christiane Brandwein; Alessia Luoni; Renaud Massart; Laurence Lanfumey; Marco Andrea Riva; Michael Deuschle; Peter Gass; Moshe Szyf
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

6.  The effects of childhood maltreatment on epigenetic regulation of stress-response associated genes: an intergenerational approach.

Authors:  Laura Ramo-Fernández; Christina Boeck; Alexandra M Koenig; Katharina Schury; Elisabeth B Binder; Harald Gündel; Jöerg M Fegert; Alexander Karabatsiakis; Iris-Tatjana Kolassa
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

7.  FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells - First insights from novel humanized mice.

Authors:  Verena Nold; Nadine Richter; Bastian Hengerer; Iris-Tatjana Kolassa; Kelly Ann Allers
Journal:  Eur J Neurosci       Date:  2020-10-27       Impact factor: 3.386

Review 8.  A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches.

Authors:  Stephanie H Parade; Lindsay Huffhines; Nicole R Nugent; Audrey R Tyrka; Teresa E Daniels; Laura R Stroud
Journal:  Transl Psychiatry       Date:  2021-02-19       Impact factor: 6.222

9.  Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives.

Authors:  Johannes Hertel; Johanna König; Georg Homuth; Sandra Van der Auwera; Katharina Wittfeld; Maik Pietzner; Tim Kacprowski; Liliane Pfeiffer; Anja Kretschmer; Melanie Waldenberger; Gabi Kastenmüller; Anna Artati; Karsten Suhre; Jerzy Adamski; Sönke Langner; Uwe Völker; Henry Völzke; Matthias Nauck; Nele Friedrich; Hans Joergen Grabe
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

10.  Understanding the Complex of Suicide in Depression: from Research to Clinics.

Authors:  Laura Orsolini; Roberto Latini; Maurizio Pompili; Gianluca Serafini; Umberto Volpe; Federica Vellante; Michele Fornaro; Alessandro Valchera; Carmine Tomasetti; Silvia Fraticelli; Marco Alessandrini; Raffaella La Rovere; Sabatino Trotta; Giovanni Martinotti; Massimo Di Giannantonio; Domenico De Berardis
Journal:  Psychiatry Investig       Date:  2020-03-23       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.